Immix Biopharma (IMMX)
(Delayed Data from NSDQ)
$2.05 USD
+0.01 (0.49%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $2.03 -0.02 (-0.98%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/09/2024
Time: -- |
6/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Immix Biopharma (IMMX) reported earnings of -$0.22 per share, beating the Zacks Consensus Estimate of $-0.23 per share. This reflects a positive earnings surprise of 4.35%. Look out for IMMX's next earnings release expected on August 09, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 12.5%.
Earnings History
Price & Consensus
Zacks News for IMMX
Immix (IMMX) CAR-T Therapy IND Cleared by FDA, Stock Down
IMMX: What are Zacks experts saying now?
Zacks Private Portfolio Services